CostLo Banner Image
Consumer Health >> Cosmopolita >>

MinoxiPlus ™ (Minoxidil 2% for women) - Woman Hair Regrowth

Product Highlights

  • FDA Registered Hair Regrowth Treatment
  • No Embarrassing Doctor Visits
  • Prevents Hair Loss and Regrows Hair
  • No Chemicals, No Creams
  • Blocks DHT
  • Discreet Shipping & Billing Worldwide
  • No Prescription Necessary

Product Details:

There's hardly anything worse than losing your hair! You stare at your comb in horror as hair of hair comes out.The drain in your shower gets stopped up with your falling hair. You've been changing your hairstyle to cover up the thin spots. You feel naked – and old! Now there's finally a hair loss treatment product for women specifically fortified for women - MinoxiPlus!

MinoxiPlus™ is fortified with Minoxidil, the ingredient clinically proven for re-growing your hair. This powerful active ingredient works in your hair follicles. Our system also includes a nourishing blend of natural herbs and minerals in a supplement formulated for women. These herbs and minerals support and provide nourishment to your scalp and hair.

In other words, saffron extract helps you avoid those sugar-ridden, calorie-loaded snacks you desire so badly. Saffron extract helps you make healthy food choices to naturally enhance your weight loss and prevent you from binge eating.

The result is a complete hair loss prevention and treatment system that can not only help regrow your hair, but improve the look and health of the hair you've already got. You won't find a women's hair loss treatment system this complete anywhere else!

For more information about this product please contact our Consumer Health Department at

    Products by Category:

Quick Contact

Stay Informed:
Recent Newsletters:
Issue #: 211 – AHD:
by Animal Health Department
Issue #: 214 – CHD:
by Consumer Health Department
Press Releases and Latest News:
Pharmapex's novel mastitis treatment offers hope to world farmers
Efficient feed-based mastitis treatment boosts livestock health with a unique microencapsulated technology.
FDA approves Farxiga to treat type 2 diabetes
The U.S. FDA today approved Farxiga (dapaglifozin) tablets to improve glycemic control, along with diet and exercise, in adults with type 2 diabetes.
FDA allows marketing of first device to relieve migraine
The U.S. FDA today allowed marketing of the Cerena Transcranial Magnetic Stimulator (TMS), the first device to relieve pain caused by migraine.
© , Pharmapex USA, A member of Apex Group of Companies, All Rights Reserved.